MedPath

Study of efficacy of Ayurvedic formulation in the management of Amavata (Rheumatoid Arthritis)

Phase 2
Conditions
Health Condition 1: M069- Rheumatoid arthritis, unspecified
Registration Number
CTRI/2021/12/038597
Lead Sponsor
il
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients of age group 18 to 65 years irrespective of sex

2. Patients diagnosed with Rheumatoid arthritis (as per predefined ACR 2010 criteria)

3. Patients with Sama condition (sign & symptoms) of the disease (Amavata)

4. Patients willing to give written informed consent and willing to participate for a period of six weeks as per the protocol requirements

Exclusion Criteria

1. Patients with complications of Rheumatoid Arthritis such as widespread inflammation, joint damage, cardio-vascular involvement etc

2. Patients who are unable to walk without support, or are confined to wheel chair or unable to participate in the study assessments due to impaired mobility.

3. Patients with poorly controlled Hypertension (�160/100 mmHg) or Diabetes Mellitus

{HbA1C >8%).

4. Patients diagnosed with other types of arthritis like septic arthritis, gout, psoriatic arthritis, Rieters disease etc.

5. Patients on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants, anticholinergics etc. or any other drugs that may have an influence on the outcome of the study.

6. Patients with unstable cardio-vascular disease.

7.Those with a history or presence of hepatic, renal, endocrine, neurological or pulmonary illness that in the opinion of the investigator may influence the study outcomes

8. Current use or history of use of alcohol or drugs or other habit forming substances such as smoking in the past 6 months

9.H/o hypersensitivity to any of the ingredients of the trial interventions

10.Pregnant women and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath